Cognitive Correlations With Cholinergic Signaling in Parkinson Disease Depend on Global Cognitive Status

Objective To determine the cholinergic pathway differences in Parkinson disease (PD) and healthy controls and whether correlations between cholinergic function and cognitive domains within PD relate to global cognitive status. Methods Cholinergic activity was measured in PD ( N = 50) and control ( N = 28) participants using the vesicular cholinergic transporter PET tracer, [ 18 F]VAT. Scans were reconstructed and partial volume corrected. Regional binding potentials were calculated using the multilinear reference tissue model 2 (MRTM2). Global cognitive status was assessed using the Clinical Dementia Rating (CDR) scale with PD participants stratified as cognitively intact (CDR = 0, N = 28) and cognitively impaired (CDR = 0.5, N = 22). Cognitive performance was measured across attention, memory, language, visuospatial, and executive function domains. Regions of interest (ROIs) were defined using all PD and control participants, identifying regions with [ 18 F]VAT‐cognitive domain correlations for subgroup analyses. Results PD participants demonstrated significantly lower [ 18 F]VAT binding relative to controls but not between PD subgroups. [ 18 F]VAT correlations were identified in whole‐group analysis for attention and visuospatial function. Stepwise linear regression revealed significant regional associations between [ 18 F]VAT and attention for the whole‐PD group and both attention and visuospatial function for the cognitively impaired PD group. In fact, the PD group with cognitive impairment exhibited strong correlations ( r > 0.5, 5% FDR) between [ 18 F]VAT and visuospatial function in almost all ROIs. Interpretation These results demonstrate that the relationship between cholinergic signaling and visuospatial function differs based on global cognitive status in PD. Significant differences in VAT binding across the full PD sample suggest that cholinergic denervation precedes cognitive impairment in PD and imply other compensatory mechanisms may exist in cognitively intact participants but this needs confirmation in longitudinal analysis.

Authors

Institutions

Publication Details

Journal
Annals of Clinical and Translational Neurology
Published
2026-11-18
DOI
https://doi.org/10.1002/acn3.70580
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cognitive Correlations With Cholinergic Signaling in Parkinson Disease Depend on Global Cognitive Status

Daniel G. Di Luca, Zhude Tu, Joel S. Perlmutter, Paul T. Kotzbauer et al.
Annals of Clinical and Translational Neurology
Parkinson's Disease Mechanisms and Treatments
article

Cognitive Correlations With Cholinergic Signaling in Parkinson Disease Depend on Global Cognitive Status

Daniel G. Di Luca, Zhude Tu, Joel S. Perlmutter, Paul T. Kotzbauer, Helen Hwang, Anil Kumar Soda, Baijayanta Maiti, Abdulmunaim M. Eid, Meghan C. Campbell, Sarah Grossen, Aaron Tanenbaum, John Hood, John O’Donnell
article en

Abstract

Objective To determine the cholinergic pathway differences in Parkinson disease (PD) and healthy controls and whether correlations between cholinergic function and cognitive domains within PD relate to global cognitive status. Methods Cholinergic activity was measured in PD ( N = 50) and control ( N = 28) participants using the vesicular cholinergic transporter PET tracer, [ 18 F]VAT. Scans were reconstructed and partial volume corrected. Regional binding potentials were calculated using the multilinear reference tissue model 2 (MRTM2). Global cognitive status was assessed using the Clinical Dementia Rating (CDR) scale with PD participants stratified as cognitively intact (CDR = 0, N = 28) and cognitively impaired (CDR = 0.5, N = 22). Cognitive performance was measured across attention, memory, language, visuospatial, and executive function domains. Regions of interest (ROIs) were defined using all PD and control participants, identifying regions with [ 18 F]VAT‐cognitive domain correlations for subgroup analyses. Results PD participants demonstrated significantly lower [ 18 F]VAT binding relative to controls but not between PD subgroups. [ 18 F]VAT correlations were identified in whole‐group analysis for attention and visuospatial function. Stepwise linear regression revealed significant regional associations between [ 18 F]VAT and attention for the whole‐PD group and both attention and visuospatial function for the cognitively impaired PD group. In fact, the PD group with cognitive impairment exhibited strong correlations ( r > 0.5, 5% FDR) between [ 18 F]VAT and visuospatial function in almost all ROIs. Interpretation These results demonstrate that the relationship between cholinergic signaling and visuospatial function differs based on global cognitive status in PD. Significant differences in VAT binding across the full PD sample suggest that cholinergic denervation precedes cognitive impairment in PD and imply other compensatory mechanisms may exist in cognitively intact participants but this needs confirmation in longitudinal analysis.

Annals of Clinical and Translational Neurology
Washington University in St. Louis (US), Hope Center for Neurological Disorders (US)
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon